Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cryoseal fibrin sealant shows promise in TKA (total knee arthroplasty):

This article was originally published in Clinica

Executive Summary

ThermoGenesis says that an early study has produced evidence to support the use of its CryoSeal autologous fibrin sealant in total knee arthroplasty (TKA). The 21-patient pilot trial showed that total blood loss in TKA was reduced by 50% when using the sealant. The CryoSeal patients also had better cardiovascular stability, a higher range of motion, less pain and better wound healing than the control group. Plans are underway to confirm the results in a larger study. It has been estimated that over 1.3 million TKA procedures are performed annually worldwide, says the Rancho Cordova, California firm. The CryoSeal FS system is CE-marked for sale in Europe.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts